{
    "references": [
        {
            "bibentry": "Nowotarski, SL, Woster, PM, Casero, RA, Jr,. Polyamines and cancer: implications for chemotherapy and chemoprevention. Expert Rev Mol Med 2013; 15: e3. PMID: 23432971",
            "process_entry": "True",
            "doi": "10.1017/erm.2013.3",
            "pmid": "23432971",
            "pmcid": "PMC4027058",
            "xmlid": "CIT0001"
        },
        {
            "bibentry": "Cervelli, M, Angelucci, E, Germani, F, et al. Inflammation, carcinogenesis and neurodegeneration studies in transgenic animal models for polyamine research. Amino Acids 2014; 46: 521–30. PMID: 23933909",
            "process_entry": "True",
            "doi": "10.1007/s00726-013-1572-3",
            "pmid": "23933909",
            "xmlid": "CIT0002"
        },
        {
            "bibentry": "Gerner, EW, Meyskens, FL, Jr,. Polyamines and cancer: old molecules, new understanding. Nat Rev Cancer 2004; 4: 781–92. PMID: 15510159",
            "process_entry": "True",
            "doi": "10.1038/nrc1454",
            "pmid": "15510159",
            "xmlid": "CIT0003"
        },
        {
            "bibentry": "Seiler, N. Oxidation of polyamines and brain injury. Neurochem Res 2000; 25: 471–90. PMID: 10823580",
            "process_entry": "True",
            "doi": "10.1023/a:1007508008731",
            "pmid": "10823580",
            "xmlid": "CIT0004"
        },
        {
            "bibentry": "Tomitori, H, Usui, T, Saeki, N, et al. Polyamine oxidase and acrolein as novel biochemical markers for diagnosis of cerebral stroke. Stroke 2005; 36: 2609–13. PMID: 16269634",
            "process_entry": "True",
            "doi": "10.1161/01.str.0000190004.36793.2d",
            "pmid": "16269634",
            "xmlid": "CIT0005"
        },
        {
            "bibentry": "Park, MH, Igarashi, K. Polyamines and their metabolites as diagnostic markers of human diseases. Biomol Ther (Seoul) 2013; 21: 1–9. PMID: 24009852",
            "process_entry": "True",
            "doi": "10.4062/biomolther.2012.097",
            "pmid": "24009852",
            "pmcid": "PMC3762300",
            "xmlid": "CIT0006"
        },
        {
            "bibentry": "Pegg, AE. Toxicity of polyamines and their metabolic products. Chem Res Toxicol 2013; 26: 1782–800. PMID: 24224555",
            "process_entry": "True",
            "doi": "10.1021/tx400316s",
            "pmid": "24224555",
            "xmlid": "CIT0007"
        },
        {
            "bibentry": "Cervelli, M, Amendola, R, Polticelli, F, Mariottini, P. Spermine oxidase: ten years after. Amino Acids 2012; 42: 441–50. PMID: 21809080",
            "process_entry": "True",
            "doi": "10.1007/s00726-011-1014-z",
            "pmid": "21809080",
            "xmlid": "CIT0008"
        },
        {
            "bibentry": "Cervelli, M, Bellavia, G, D'Amelio, M. A new transgenic mouse model for studying the neurotoxicity of spermine oxidase dosage in the response to excitotoxic injury. PLoS One 2013; 8: e64810. PMID: 23840306",
            "process_entry": "True",
            "doi": "10.1371/journal.pone.0064810",
            "pmid": "23840306",
            "pmcid": "PMC3686797",
            "xmlid": "CIT0009"
        },
        {
            "bibentry": "Cervetto, C, Vergani, L, Passalacqua, M, et al. Astrocyte-dependent vulnerability to excitotoxicity in spermine oxidase-overexpressing mouse. Neuromolecular Med 2016; 18: 50–68. PMID: 26530396",
            "process_entry": "True",
            "doi": "10.1007/s12017-015-8377-3",
            "pmid": "26530396",
            "xmlid": "CIT0010"
        },
        {
            "bibentry": "Sharmin, S, Sakata, K, Kashiwagi, K, et al. Polyamine cytotoxicity in the presence of bovine serum amine oxidase. Biochem Biophys Res Commun 2001; 282: 228–35. PMID: 11263996",
            "process_entry": "True",
            "doi": "10.1006/bbrc.2001.4569",
            "pmid": "11263996",
            "xmlid": "CIT0011"
        },
        {
            "bibentry": "Agostinelli, E, Belli, F, Molinari, A, et al. Toxicity of enzymatic oxidation products of spermine to human melanoma cells (M14): sensitization by heat and MDL 72527. Biochim Biophis Acta 2006; 1763: 1040–50.",
            "process_entry": "True",
            "xmlid": "CIT0012"
        },
        {
            "bibentry": "Agostinelli, E, Condello, M, Tempera, G, et al. The combined treatment with chloroquine and the enzymatic oxidation products of spermine overcomes multidrug resistance of melanoma M14 ADR2 cells: a new therapeutic approach. Int J Oncol 2014; 45: 1109–22. PMID: 24969157",
            "process_entry": "True",
            "doi": "10.3892/ijo.2014.2502",
            "pmid": "24969157",
            "xmlid": "CIT0013"
        },
        {
            "bibentry": "Wallace, HM, Fraser, AV. Inhibitors of polyamine metabolism: review article. Amino Acids 2004; 26: 353–65. PMID: 15290341",
            "process_entry": "True",
            "doi": "10.1007/s00726-004-0092-6",
            "pmid": "15290341",
            "xmlid": "CIT0014"
        },
        {
            "bibentry": "Amendola, R, Cervelli, M, Tempera, G, et al. Spermine metabolism and radiation-derived reactive oxygen species for future therapeutic implications in cancer: an additive or adaptive response. Amino Acids 2014; 46: 487–98. PMID: 23999645",
            "process_entry": "True",
            "doi": "10.1007/s00726-013-1579-9",
            "pmid": "23999645",
            "xmlid": "CIT0015"
        },
        {
            "bibentry": "Casero, RA, Jr, Marton, LJ. Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases. Nat Rev Drug Discov 2007; 6: 373–90. PMID: 17464296",
            "process_entry": "True",
            "doi": "10.1038/nrd2243",
            "pmid": "17464296",
            "xmlid": "CIT0016"
        },
        {
            "bibentry": "Calcabrini, A, Arancia, G, Marra, M, et al. Enzymatic oxidation products of spermine induce greater cytotoxic effects on human multidrug-resistant colon carcinoma cells (LoVo) than on their wild-type counterparts. Int J Cancer 2002; 99: 43–52. PMID: 11948490",
            "process_entry": "True",
            "doi": "10.1002/ijc.10310",
            "pmid": "11948490",
            "xmlid": "CIT0017"
        },
        {
            "bibentry": "Murray-Stewart, TR, Woster, PM, Casero, RA, Jr,. Targeting polyamine metabolism for cancer therapy and prevention. Biochem J 2016; 473: 2937–53. PMID: 27679855",
            "process_entry": "True",
            "doi": "10.1042/BCJ20160383",
            "pmid": "27679855",
            "pmcid": "PMC5711482",
            "xmlid": "CIT0018"
        },
        {
            "bibentry": "Casero, RA, Jr, Pegg, AE. Polyamine catabolism and disease. Biochem J 2009; 421: 323–38. PMID: 19589128",
            "process_entry": "True",
            "doi": "10.1042/BJ20090598",
            "pmid": "19589128",
            "pmcid": "PMC2756025",
            "xmlid": "CIT0019"
        },
        {
            "bibentry": "Murray Stewart, T, Dunston, TT, Woster, PM, Casero, RA, Jr,. Polyamine catabolism and oxidative damage. J Biol Chem 2018; 293: 18736–45. PMID: 30333229",
            "process_entry": "True",
            "doi": "10.1074/jbc.tm118.003337",
            "pmid": "30333229",
            "xmlid": "CIT0020"
        },
        {
            "bibentry": "Pozzi, MH, Gawandi, V, Fitzpatrick, PF. Mechanistic studies of para-substituted N,N'-dibenzyl-1,4-diaminobutanes as substrates for a mammalian polyamine oxidase. Biochemistry 2009; 48: 12305–13. PMID: 19911805",
            "process_entry": "True",
            "doi": "10.1021/bi901694s",
            "pmid": "19911805",
            "pmcid": "PMC2797579",
            "xmlid": "CIT0021"
        },
        {
            "bibentry": "Cervelli, M, Salvi, D, Polticelli, F, et al. Structure-function relationships in the evolutionary framework of spermine oxidase. J Mol Evol 2013; 76: 365–70. PMID: 23828398",
            "process_entry": "True",
            "doi": "10.1007/s00239-013-9570-3",
            "pmid": "23828398",
            "xmlid": "CIT0022"
        },
        {
            "bibentry": "Polticelli, F, Salvi, D, Mariottini, P, et al. Molecular evolution of the polyamine oxidase gene family in Metazoa. BMC Evol Biol 2012; 12: 90. PMID: 22716069",
            "process_entry": "True",
            "doi": "10.1186/1471-2148-12-90",
            "pmid": "22716069",
            "pmcid": "PMC3517346",
            "xmlid": "CIT0023"
        },
        {
            "bibentry": "Wang, Y, Hacker, A, Murray-Stewart, T, et al. Properties of recombinant human N1-acetylpolyamine oxidase (hPAO): potential role in determining drug sensitivity. Cancer Chemother Pharmacol 2005; 56: 83–90. PMID: 15791459",
            "process_entry": "True",
            "doi": "10.1007/s00280-004-0936-5",
            "pmid": "15791459",
            "xmlid": "CIT0024"
        },
        {
            "bibentry": "Cervelli, M, Bellini, A, Bianchi, M, et al. Mouse spermine oxidase gene splice variants. Nuclear subcellular localization of a novel active isoform. Eur J Biochem 2004; 271: 760–70. PMID: 14764092",
            "process_entry": "True",
            "doi": "10.1111/j.1432-1033.2004.03979.x",
            "pmid": "14764092",
            "xmlid": "CIT0025"
        },
        {
            "bibentry": "Cervelli, M, Fratini, E, Amendola, R, et al. Increased spermine oxidase (SMO) activity as a novel differentiation marker of myogenic C2C12 cells. Int J Biochem Cell Biol 2009; 41: 934–44. PMID: 18852063",
            "process_entry": "True",
            "doi": "10.1016/j.biocel.2008.09.009",
            "pmid": "18852063",
            "xmlid": "CIT0026"
        },
        {
            "bibentry": "Bongers, KS, Fox, DK, Kunkel, SD, et al. Spermine oxidase maintains basal skeletal muscle gene expression and fiber size and is strongly repressed by conditions that cause skeletal muscle atrophy. Am J Physiol Endocrinol Metab 2015; 308: E144–58. PMID: 25406264",
            "process_entry": "True",
            "doi": "10.1152/ajpendo.00472.2014",
            "pmid": "25406264",
            "pmcid": "PMC4297781",
            "xmlid": "CIT0027"
        },
        {
            "bibentry": "Bonaiuto, E, Grancara, S, Martinis, P, et al. A novel enzyme with spermine oxidase properties in bovine liver mitochondria: identification and kinetic characterization. Free Radic Biol Med 2015; 82: 88–99.",
            "process_entry": "True",
            "xmlid": "CIT0028"
        },
        {
            "bibentry": "Goodwin, AC, Jadallah, S, Toubaji, A, et al. Increased spermine oxidase expression in human prostate cancer and prostatic intraepithelial neoplasia tissues. Prostate 2008; 68: 766–72. PMID: 18302221",
            "process_entry": "True",
            "doi": "10.1002/pros.20735",
            "pmid": "18302221",
            "pmcid": "PMC3065872",
            "xmlid": "CIT0029"
        },
        {
            "bibentry": "Chaturvedi, R, Asim, M, Romero-Gallo, J, et al. Spermine oxidase mediates the gastric cancer risk associated with Helicobacter pylori CagA. Gastroenterology 2011; 141: 1696–708. PMID: 21839041",
            "process_entry": "True",
            "doi": "10.1053/j.gastro.2011.07.045",
            "pmid": "21839041",
            "pmcid": "PMC3202654",
            "xmlid": "CIT0030"
        },
        {
            "bibentry": "Hu, T, Sun, D, Zhang, J, et al. Spermine oxidase is upregulated and promotes tumor growth in hepatocellular carcinoma. Hepatol Res 2018; 48: 967–77. PMID: 29923661",
            "process_entry": "True",
            "doi": "10.1111/hepr.13206",
            "pmid": "29923661",
            "xmlid": "CIT0031"
        },
        {
            "bibentry": "Murray-Stewart, T, Sierra, JC, Piazuelo, MB, et al. Epigenetic silencing of miR-124 prevents spermine oxidase regulation: implications for Helicobacter pylori-induced gastric cancer. Oncogene 2016; 35: 5480–8. PMID: 27041578",
            "process_entry": "True",
            "doi": "10.1038/onc.2016.91",
            "pmid": "27041578",
            "pmcid": "PMC5050049",
            "xmlid": "CIT0032"
        },
        {
            "bibentry": "Bianchi, M, Polticelli, F, Ascenzi, P, et al. Inhibition of polyamine and spermine oxidases by polyamine analogues. FEBS J 2006; 273: 1115–23. PMID: 16519678",
            "process_entry": "True",
            "doi": "10.1111/j.1742-4658.2006.05137.x",
            "pmid": "16519678",
            "xmlid": "CIT0033"
        },
        {
            "bibentry": "Bey, P, Bolkenius, FN, Seiler, N, Casara, PN. 2,3-Butadienyl-1,4-butanediamine derivatives: potent irreversible inactivators of mammalian polyamine oxidase. J Med Chem 1985; 28: 1–2. PMID: 3965702",
            "process_entry": "True",
            "doi": "10.1021/jm00379a001",
            "pmid": "3965702",
            "xmlid": "CIT0034"
        },
        {
            "bibentry": "Moriya, SS, Miura, T, Takao, K, et al. Development of irreversible inactivators of spermine oxidase and N 1-acetylpolyamine oxidase. Biol Pharm Bull 2014; 37: 475–80. PMID: 24583866",
            "process_entry": "True",
            "doi": "10.1248/bpb.b13-00913",
            "pmid": "24583866",
            "xmlid": "CIT0035"
        },
        {
            "bibentry": "Cervelli, M, Polticelli, F, Fiorucci, L, et al. Inhibition of acetylpolyamine and spermine oxidases by the polyamine analogue chlorhexidine. J Enzyme Inhib Med Chem 2013; 28: 463–7. PMID: 22299575",
            "process_entry": "True",
            "doi": "10.3109/14756366.2011.650691",
            "pmid": "22299575",
            "xmlid": "CIT0036"
        },
        {
            "bibentry": "Sjögren, T, Wassvik, CM, Snijder, A, et al. The structure of murine N 1 acetylspermine oxidase reveals molecular details of vertebrate polyamine catabolism. Biochemistry 2017; 56: 458–67. PMID: 28029774",
            "process_entry": "True",
            "doi": "10.1021/acs.biochem.6b01140",
            "pmid": "28029774",
            "xmlid": "CIT0037"
        },
        {
            "bibentry": "Tavladoraki, P, Cervelli, M, Antonangeli, F, et al. Probing mammalian spermine oxidase enzyme-substrate complex through molecular modeling, site-directed mutagenesis and biochemical characterization. Amino Acids 2011; 40: 1115–26. PMID: 20839014",
            "process_entry": "True",
            "doi": "10.1007/s00726-010-0735-8",
            "pmid": "20839014",
            "xmlid": "CIT0038"
        },
        {
            "bibentry": "Leonetti, A, Cervoni, L, Polticelli, F, et al. Spectroscopic and calorimetric characterization of spermine oxidase and its association forms. Biochem J 2017; 474: 4253–68. PMID: 29138259",
            "process_entry": "True",
            "doi": "10.1042/bcj20170744",
            "pmid": "29138259",
            "xmlid": "CIT0039"
        },
        {
            "bibentry": "Cervelli, M, Angelucci, E, Stano, P, et al. The Glu 216/Ser 218 pocket is a major determinant of spermine oxidase substrate specificity. Biochem J 2014; 461: 453–9. PMID: 24854736",
            "process_entry": "True",
            "doi": "10.1042/bj20140305",
            "pmid": "24854736",
            "xmlid": "CIT0040"
        },
        {
            "bibentry": "Polticelli, F, Basran, J, Faso, C, et al. Lys300 plays a major role in the catalytic mechanism of maize polyamine oxidase. Biochemistry 2005; 44: 16108–20. PMID: 16331971",
            "process_entry": "True",
            "doi": "10.1021/bi050983i",
            "pmid": "16331971",
            "xmlid": "CIT0041"
        },
        {
            "bibentry": "Henderson Pozzi, M, Gawandi, V, Fitzpatrick, PF. pH dependence of a mammalian polyamine oxidase: insights into substrate specificity and the role of lysine 315. Biochemistry 2009; 48: 1508–16. PMID: 19199575",
            "process_entry": "True",
            "doi": "10.1021/bi802227m",
            "pmid": "19199575",
            "pmcid": "PMC2752350",
            "xmlid": "CIT0042"
        },
        {
            "bibentry": "Minarini, A, Milelli, A, Tumiatti, V, et al. Synthetic polyamines: an overview of their multiple biological activities. Amino Acids 2010; 38: 383–92. PMID: 20012115",
            "process_entry": "True",
            "doi": "10.1007/s00726-009-0430-9",
            "pmid": "20012115",
            "xmlid": "CIT0043"
        },
        {
            "bibentry": "Melchiorre, C, Bolognesi, ML, Minarini, A, et al. Polyamines in drugs discovery: from the universal template approach to the multitarget–directed ligand design strategy. J Med Chem 2010; 53: 5906–14. PMID: 20420456",
            "process_entry": "True",
            "doi": "10.1021/jm100293f",
            "pmid": "20420456",
            "xmlid": "CIT0044"
        },
        {
            "bibentry": "Bradford, MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248–54. PMID: 942051",
            "process_entry": "True",
            "doi": "10.1006/abio.1976.9999",
            "pmid": "942051",
            "xmlid": "CIT0045"
        },
        {
            "bibentry": "Bonaiuto, E, Minarini, A, Tumiatti, V, et al. Synthetic polyamines as potential amine oxidase inhibitors: a preliminary study. Amino Acids 2012; 42: 913–28. PMID: 21858471",
            "process_entry": "True",
            "doi": "10.1007/s00726-011-1006-z",
            "pmid": "21858471",
            "xmlid": "CIT0046"
        },
        {
            "bibentry": "Bonaiuto, E, Milelli, A, Cozza, G, et al. Novel polyamine analogues: from substrates towards potential inhibitors of monoamine oxidases. Eur J Med Chem 2013; 70: 88–101. PMID: 24140951",
            "process_entry": "True",
            "doi": "10.1016/j.ejmech.2013.07.005",
            "pmid": "24140951",
            "xmlid": "CIT0047"
        },
        {
            "bibentry": "Melchiorre, C, Minarini, A, Quaglia, W, Tumiatti, V. Methoctramine. Drugs Future 1989; 14: 628–31.",
            "process_entry": "True",
            "xmlid": "CIT0048"
        },
        {
            "bibentry": "Minarini, A, Budriesi, R, Chiarini, A, et al. Further investigation on methoctramine-related tetraamines: effects of terminal N-substitution and of chain length separating the four nitrogens on M 2 muscarinic receptor blocking activity. Farmaco 1991; 46: 1167–78. PMID: 1815579",
            "process_entry": "True",
            "pmid": "1815579",
            "xmlid": "CIT0049"
        },
        {
            "bibentry": "Tumiatti, V, Minarini, A, Milelli, A, et al. Structure-activity relationships of methoctramine-related polyamines as muscarinic antagonist: effect of replacing the inner polymethylene chain with cyclic moieties. Bioorg Med Chem 2007; 15: 2312–21. PMID: 17276075",
            "process_entry": "True",
            "doi": "10.1016/j.bmc.2007.01.022",
            "pmid": "17276075",
            "xmlid": "CIT0050"
        },
        {
            "bibentry": "Melchiorre, C, Andrisano, M, Bolognesi, ML, et al. Acetylcholinesterase noncovalent inhibitors based on a polyamine backbone for potential use against Alzheimer’s disease. J Med Chem 1998; 41: 4186–9. PMID: 9784091",
            "process_entry": "True",
            "doi": "10.1021/jm9810452",
            "pmid": "9784091",
            "xmlid": "CIT0051"
        },
        {
            "bibentry": "Zhou, N, Panchuk-Voloshina, N. A one-step fluorometric method for the continuous measurement of monoamine oxidase activity. Anal. Biochem 1997; 253: 169–74. PMID: 9367499",
            "process_entry": "True",
            "doi": "10.1006/abio.1997.2392",
            "pmid": "9367499",
            "xmlid": "CIT0052"
        },
        {
            "bibentry": "Corazza, A, Stevanato, R, Di Paolo, ML, et al. Effect of phosphate ion on the activity of bovine plasma amine oxidase. Biochem Biophys Res Commun 1992; 189: 722–7. PMID: 1472044",
            "process_entry": "True",
            "doi": "10.1016/0006-291x(92)92261-u",
            "pmid": "1472044",
            "xmlid": "CIT0053"
        },
        {
            "bibentry": "Ionescu, CM, Sehnal, D, Falginella, FL, et al. AtomicChargeCalculator: interactive web-based calculation of atomic charges in large biomolecular complexes and drug like molecules. J Cheminform 2015; 7: 50. PMID: 26500704",
            "process_entry": "True",
            "doi": "10.1186/s13321-015-0099-x",
            "pmid": "26500704",
            "pmcid": "PMC4613891",
            "xmlid": "CIT0054"
        },
        {
            "bibentry": "Trott, O, Olson, AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comp Chem 2010; 31: 455–61. PMID: 19499576",
            "process_entry": "True",
            "doi": "10.1002/jcc.21334",
            "pmid": "19499576",
            "pmcid": "PMC3041641",
            "xmlid": "CIT0055"
        },
        {
            "bibentry": "Laemmli, UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680–5. PMID: 5432063",
            "process_entry": "True",
            "doi": "10.1038/227680a0",
            "pmid": "5432063",
            "xmlid": "CIT0056"
        },
        {
            "bibentry": "Häkkinen, MR, Hyvönen, M, Auriola, S, et al. Metabolism of N-alkylated spermine analogues by polyamine and spermine oxidases. Amino Acids 2010; 38: 369–81. PMID: 20012116",
            "process_entry": "True",
            "doi": "10.1007/s00726-009-0429-2",
            "pmid": "20012116",
            "pmcid": "PMC2992990",
            "xmlid": "CIT0057"
        },
        {
            "bibentry": "Bonaiuto, E, Lunelli, M, Scarpa, M, et al. A structure-activity study to identify novel and efficient substrates of the human semicarbazide-sensitive amine oxidase/VAP-1 enzyme. Biochimie 2010; 92: 858–68. PMID: 20298739",
            "process_entry": "True",
            "doi": "10.1016/j.biochi.2010.03.006",
            "pmid": "20298739",
            "xmlid": "CIT0058"
        },
        {
            "bibentry": "Liu, J, Li, L, Suo, WZ. HT22 hippocampal neuronal cell line possesses functional cholinergic properties. Life Sci 2009; 84: 267–71. PMID: 19135458",
            "process_entry": "True",
            "doi": "10.1016/j.lfs.2008.12.008",
            "pmid": "19135458",
            "xmlid": "CIT0059"
        },
        {
            "bibentry": "Lee, DS, Ko, W, Kim, DC, et al. Cudarflavone B provides neuroprotection against glutamate-induced mouse hippocampal HT22cell damage through the Nrf2 and PI3K/Akt signaling pathways. Molecules 2014; 19: 10818–31. PMID: 25061726",
            "process_entry": "True",
            "doi": "10.3390/molecules190810818",
            "pmid": "25061726",
            "pmcid": "PMC6271666",
            "xmlid": "CIT0060"
        },
        {
            "bibentry": "Cao, X, Wei, Z, Gabriel, GG, et al. Calcium-sensitive regulation of monoamine oxidase-A contributes to the production of peroxyradicals in hippocampal cultures: implications for Alzheimer disease-related pathology. BMC Neurosci 2007; 8: 73. PMID: 17868476",
            "process_entry": "True",
            "doi": "10.1186/1471-2202-8-73",
            "pmid": "17868476",
            "pmcid": "PMC2048967",
            "xmlid": "CIT0061"
        },
        {
            "bibentry": "Sawa, K, Uematsu, T, Korenaga, Y, et al. Krebs cycle intermediates protective against oxidative stress by modulating the level of reactive oxygen species in neuronal HT22. Cells 2017; 6: E21. PMID: 28698482",
            "process_entry": "True",
            "doi": "10.3390/cells6030021",
            "pmid": "28698482",
            "pmcid": "PMC5617967",
            "xmlid": "CIT0062"
        },
        {
            "bibentry": "Averill-Bates, DA, Cherif, A, Agostinelli, E, et al. Anti-tumoral effect of native and immobilized bovine serum amine oxidase in a mouse melanoma model. Biochem Pharmacol 2005; 69: 1693–704. PMID: 15935145",
            "process_entry": "True",
            "doi": "10.1016/j.bcp.2005.02.025",
            "pmid": "15935145",
            "xmlid": "CIT0063"
        },
        {
            "bibentry": "Averill-Bates, DA, Ke, Q, Tanel, A, et al. Mechanism of cell death induced by spermine and amine oxidase in mouse melanoma cells. Int J Oncol 2008; 32: 79–88. PMID: 18097545",
            "process_entry": "True",
            "pmid": "18097545",
            "xmlid": "CIT0064"
        },
        {
            "bibentry": "Weisell, J, Hyvo¨nen, MT, Ha¨kkinen, MR, et al. Synthesis and biological characterization of novel charge-deficient spermine analogues. J Med Chem 2010; 53: 5738–48. PMID: 20684609",
            "process_entry": "True",
            "doi": "10.1021/jm100439p",
            "pmid": "20684609",
            "xmlid": "CIT0065"
        },
        {
            "bibentry": "Ucal, S, Häkkinen, MR, Alanne, AL, et al. Controlling of N-alkylpolyamine analogue metabolism by selective deuteration. Biochem J 2018; 475: 663–76. PMID: 29301981",
            "process_entry": "True",
            "doi": "10.1042/bcj20170887",
            "pmid": "29301981",
            "xmlid": "CIT0066"
        },
        {
            "bibentry": "Takao, K, Shirahata, A, Samejima, K, et al. Pentamines as substrate for human spermine oxidase. Biol Pharm Bull 2013; 36: 407–11. PMID: 23449327",
            "process_entry": "True",
            "doi": "10.1248/bpb.b12-00818",
            "pmid": "23449327",
            "pmcid": "PMC3602902",
            "xmlid": "CIT0067"
        },
        {
            "bibentry": "Goodwin, AC, Shields, CED, Wu, S, et al. Polyamine catabolism contributes to enterotoxigenic Bacteroides fragilis-induced colon tumorigenesis. Proc Natl Acad Sci USA 2011; 108: 15354–9. PMID: 21876161",
            "process_entry": "True",
            "doi": "10.1073/pnas.1010203108",
            "pmid": "21876161",
            "pmcid": "PMC3174648",
            "xmlid": "CIT0068"
        },
        {
            "bibentry": "Chaturvedi, R, de Sablet, T, Asim, M, et al. Increased Helicobacter pylori-associated gastric cancer risk in the Andean region of Colombia is mediated by spermine oxidase. Oncogene 2015; 34: 3429–40. PMID: 25174398",
            "process_entry": "True",
            "doi": "10.1038/onc.2014.273",
            "pmid": "25174398",
            "pmcid": "PMC4345146",
            "xmlid": "CIT0069"
        },
        {
            "bibentry": "Melchiorre, C, Minarini, A, Angeli, P, et al. Polymethylene tetraamines as muscarinic receptor probes. Trends Pharmacol Sci 1989;Suppl: 55–9. PMID: 2694524",
            "process_entry": "True",
            "pmid": "2694524",
            "xmlid": "CIT0070"
        },
        {
            "bibentry": "Zini, M, Passariello, CL, Gottardi, D, et al. Cytotoxicity of methoctramine and methoctramine-related polyamines. Chem Biol Interact 2009; 181: 409–16. PMID: 19576191",
            "process_entry": "True",
            "doi": "10.1016/j.cbi.2009.06.015",
            "pmid": "19576191",
            "xmlid": "CIT0071"
        },
        {
            "bibentry": "Minarini, A, Zini, M, Milelli, A, et al. Synthetic polyamines activating autophagy: effects on cancer cell death. Eur J Med Chem 2013; 67: 359–66. PMID: 23887056",
            "process_entry": "True",
            "doi": "10.1016/j.ejmech.2013.06.044",
            "pmid": "23887056",
            "xmlid": "CIT0072"
        }
    ],
    "localid": "MED-30829081",
    "doi": "10.1080/14756366.2019.1584620",
    "pmid": "10.1080/14756366.2019.1584620",
    "pmcid": "30829081",
    "curator": "BEE EuropeanPubMedCentralProcessor",
    "source_provider": "Europe PubMed Central",
    "source": "https://www.ebi.ac.uk/europepmc/webservices/rest/30829081/fullTextXML",
    "reference_pointers": [
        [
            {
                "n_rp": 0,
                "xref_id": "CIT0001",
                "rp_string": "1",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),1,183)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 1,
                "xref_id": "CIT0002",
                "rp_string": "2",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),1,183)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 2,
                "xref_id": "CIT0003",
                "rp_string": "3",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),185,353)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "Polyamine (PA) metabolism plays an important role in cellular homeostasis, and its dysregulation may contribute to the development of several pathological states, including cancer1,2. Elevated concentrations of polyamines have been associated with various types of tumours3; an increase in PA catabolism reaction products, which are reactive oxygen species and aldehydes (such as acrolein), has been implicated in causing cytotoxicity and in the pathogenesis of various diseases, such as liver and neurological disorders, and stroke4–11. For these reasons, the PA metabolic pathway has been considered as a rational target for therapeutic approaches1,12–18. To develop anti-cancer drugs, several PA analogues were designed to ‘hit’ some of the many players of this complex pathway.",
                "pl_xpath": "/article/body/sec[1]/p[1]"
            },
            {
                "n_rp": 4,
                "xref_id": "CIT0004",
                "rp_string": "4–11",
                "pl_string": "Polyamine (PA) metabolism plays an important role in cellular homeostasis, and its dysregulation may contribute to the development of several pathological states, including cancer1,2. Elevated concentrations of polyamines have been associated with various types of tumours3; an increase in PA catabolism reaction products, which are reactive oxygen species and aldehydes (such as acrolein), has been implicated in causing cytotoxicity and in the pathogenesis of various diseases, such as liver and neurological disorders, and stroke4–11. For these reasons, the PA metabolic pathway has been considered as a rational target for therapeutic approaches1,12–18. To develop anti-cancer drugs, several PA analogues were designed to ‘hit’ some of the many players of this complex pathway.",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[4]",
                "pl_xpath": "/article/body/sec[1]/p[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),185,353)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 4,
                "xref_id": "CIT0004",
                "rp_string": "4–11",
                "pl_string": "Polyamine (PA) metabolism plays an important role in cellular homeostasis, and its dysregulation may contribute to the development of several pathological states, including cancer1,2. Elevated concentrations of polyamines have been associated with various types of tumours3; an increase in PA catabolism reaction products, which are reactive oxygen species and aldehydes (such as acrolein), has been implicated in causing cytotoxicity and in the pathogenesis of various diseases, such as liver and neurological disorders, and stroke4–11. For these reasons, the PA metabolic pathway has been considered as a rational target for therapeutic approaches1,12–18. To develop anti-cancer drugs, several PA analogues were designed to ‘hit’ some of the many players of this complex pathway.",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[4]",
                "pl_xpath": "/article/body/sec[1]/p[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),185,353)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 5,
                "xref_id": "",
                "pl_string": "4–11",
                "pl_xpath": "/article/body/sec[1]/p[1]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),185,353)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 6,
                "xref_id": "",
                "pl_string": "4–11",
                "pl_xpath": "/article/body/sec[1]/p[1]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),185,353)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 7,
                "xref_id": "",
                "pl_string": "4–11",
                "pl_xpath": "/article/body/sec[1]/p[1]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),185,353)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 8,
                "xref_id": "",
                "pl_string": "4–11",
                "pl_xpath": "/article/body/sec[1]/p[1]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),185,353)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 9,
                "xref_id": "",
                "pl_string": "4–11",
                "pl_xpath": "/article/body/sec[1]/p[1]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),185,353)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 10,
                "xref_id": "",
                "pl_string": "4–11",
                "pl_xpath": "/article/body/sec[1]/p[1]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),185,353)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 11,
                "xref_id": "",
                "pl_string": "4–11",
                "pl_xpath": "/article/body/sec[1]/p[1]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),185,353)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 12,
                "xref_id": "CIT0001",
                "rp_string": "1",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[5]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),539,119)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 20,
                "xref_id": "CIT0012",
                "rp_string": "12–18",
                "pl_string": "12–18",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[6]",
                "pl_xpath": "/article/body/sec[1]/p[1]/xref[6]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),539,119)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 14,
                "xref_id": "",
                "pl_string": "12–18",
                "pl_xpath": "/article/body/sec[1]/p[1]/xref[6]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),539,119)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 15,
                "xref_id": "",
                "pl_string": "12–18",
                "pl_xpath": "/article/body/sec[1]/p[1]/xref[6]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),539,119)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 16,
                "xref_id": "",
                "pl_string": "12–18",
                "pl_xpath": "/article/body/sec[1]/p[1]/xref[6]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),539,119)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 17,
                "xref_id": "",
                "pl_string": "12–18",
                "pl_xpath": "/article/body/sec[1]/p[1]/xref[6]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),539,119)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 18,
                "xref_id": "",
                "pl_string": "12–18",
                "pl_xpath": "/article/body/sec[1]/p[1]/xref[6]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),539,119)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 19,
                "xref_id": "",
                "pl_string": "12–18",
                "pl_xpath": "/article/body/sec[1]/p[1]/xref[6]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),539,119)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 20,
                "xref_id": "CIT0012",
                "rp_string": "12–18",
                "pl_string": "12–18",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[6]",
                "pl_xpath": "/article/body/sec[1]/p[1]/xref[6]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),539,119)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 21,
                "xref_id": "CIT0001",
                "rp_string": "1",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1,513)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "To reduce the naturally occurring PA availability in cancer cells, some of the developed analogues targeting the biosynthetic pathway are, for instance, difluoromethyl-ornithine, which inhibits ornithine decarboxylase (ODC, the rate-limiting enzyme in the synthetic pathway)1,3,18, methylglyoxal(bis)guanylhydrazone, which targets S-adenosylmethionine decarboxylase1,3,18 and the spermine (SPM) derivative named AMXT1501, which blocks the activity of polyamine transporters, avoiding the uptake of exogenous PA18. In the last years, the PA catabolic pathway is also emerging as a promising target for chemoprevention1,18–20. In addition to spermidine/spermine N1-acetyltransferase (SSAT), two other key enzymes of this pathway are acetylpolyamine oxidase (PAOX) and spermine oxidase (SMOX), which are H2O2 producers. PAOX and SMOX, FAD-containing amine oxidases, have been biochemically characterised in a wide variety of organisms, including vertebrates, invertebrates and yeast8,21–23. PAOX is a constitutively expressed enzyme and its preferred substrates are N1-acetylspermine (N1AcSPM) and N1-acetylspermidine24, whereas SMOX is an inducible enzyme specific for SPM8 and is highly expressed in some tissues, such as brain and skeletal muscle25–27. Recently, in addition to the cytoplasmic and nuclear SMOX isoforms, SMOX activity was detected also in mitochondria28. SMOX expression is increased in some type of cancers, it is induced by some bacterial infections and inflammatory cytokines, and by some PA analogues, such as N1,N11-bis(ethyl)norspermine (BenSPM)1,8,20,29–31. In each case, the induction of SMOX is linked to an increase of H2O2 production and DNA damage, which correlates with the risk of developing dysplasia/cancer18,20. In addition, epigenetic factors have been recently involved in the link between increased SMOX expression and carcinogenesis32.",
                "pl_xpath": "/article/body/sec[1]/p[2]"
            },
            {
                "n_rp": 22,
                "xref_id": "CIT0003",
                "rp_string": "3",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1,513)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "To reduce the naturally occurring PA availability in cancer cells, some of the developed analogues targeting the biosynthetic pathway are, for instance, difluoromethyl-ornithine, which inhibits ornithine decarboxylase (ODC, the rate-limiting enzyme in the synthetic pathway)1,3,18, methylglyoxal(bis)guanylhydrazone, which targets S-adenosylmethionine decarboxylase1,3,18 and the spermine (SPM) derivative named AMXT1501, which blocks the activity of polyamine transporters, avoiding the uptake of exogenous PA18. In the last years, the PA catabolic pathway is also emerging as a promising target for chemoprevention1,18–20. In addition to spermidine/spermine N1-acetyltransferase (SSAT), two other key enzymes of this pathway are acetylpolyamine oxidase (PAOX) and spermine oxidase (SMOX), which are H2O2 producers. PAOX and SMOX, FAD-containing amine oxidases, have been biochemically characterised in a wide variety of organisms, including vertebrates, invertebrates and yeast8,21–23. PAOX is a constitutively expressed enzyme and its preferred substrates are N1-acetylspermine (N1AcSPM) and N1-acetylspermidine24, whereas SMOX is an inducible enzyme specific for SPM8 and is highly expressed in some tissues, such as brain and skeletal muscle25–27. Recently, in addition to the cytoplasmic and nuclear SMOX isoforms, SMOX activity was detected also in mitochondria28. SMOX expression is increased in some type of cancers, it is induced by some bacterial infections and inflammatory cytokines, and by some PA analogues, such as N1,N11-bis(ethyl)norspermine (BenSPM)1,8,20,29–31. In each case, the induction of SMOX is linked to an increase of H2O2 production and DNA damage, which correlates with the risk of developing dysplasia/cancer18,20. In addition, epigenetic factors have been recently involved in the link between increased SMOX expression and carcinogenesis32.",
                "pl_xpath": "/article/body/sec[1]/p[2]"
            },
            {
                "n_rp": 23,
                "xref_id": "CIT0018",
                "rp_string": "18",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1,513)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "To reduce the naturally occurring PA availability in cancer cells, some of the developed analogues targeting the biosynthetic pathway are, for instance, difluoromethyl-ornithine, which inhibits ornithine decarboxylase (ODC, the rate-limiting enzyme in the synthetic pathway)1,3,18, methylglyoxal(bis)guanylhydrazone, which targets S-adenosylmethionine decarboxylase1,3,18 and the spermine (SPM) derivative named AMXT1501, which blocks the activity of polyamine transporters, avoiding the uptake of exogenous PA18. In the last years, the PA catabolic pathway is also emerging as a promising target for chemoprevention1,18–20. In addition to spermidine/spermine N1-acetyltransferase (SSAT), two other key enzymes of this pathway are acetylpolyamine oxidase (PAOX) and spermine oxidase (SMOX), which are H2O2 producers. PAOX and SMOX, FAD-containing amine oxidases, have been biochemically characterised in a wide variety of organisms, including vertebrates, invertebrates and yeast8,21–23. PAOX is a constitutively expressed enzyme and its preferred substrates are N1-acetylspermine (N1AcSPM) and N1-acetylspermidine24, whereas SMOX is an inducible enzyme specific for SPM8 and is highly expressed in some tissues, such as brain and skeletal muscle25–27. Recently, in addition to the cytoplasmic and nuclear SMOX isoforms, SMOX activity was detected also in mitochondria28. SMOX expression is increased in some type of cancers, it is induced by some bacterial infections and inflammatory cytokines, and by some PA analogues, such as N1,N11-bis(ethyl)norspermine (BenSPM)1,8,20,29–31. In each case, the induction of SMOX is linked to an increase of H2O2 production and DNA damage, which correlates with the risk of developing dysplasia/cancer18,20. In addition, epigenetic factors have been recently involved in the link between increased SMOX expression and carcinogenesis32.",
                "pl_xpath": "/article/body/sec[1]/p[2]"
            },
            {
                "n_rp": 24,
                "xref_id": "CIT0001",
                "rp_string": "1",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1,513)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "To reduce the naturally occurring PA availability in cancer cells, some of the developed analogues targeting the biosynthetic pathway are, for instance, difluoromethyl-ornithine, which inhibits ornithine decarboxylase (ODC, the rate-limiting enzyme in the synthetic pathway)1,3,18, methylglyoxal(bis)guanylhydrazone, which targets S-adenosylmethionine decarboxylase1,3,18 and the spermine (SPM) derivative named AMXT1501, which blocks the activity of polyamine transporters, avoiding the uptake of exogenous PA18. In the last years, the PA catabolic pathway is also emerging as a promising target for chemoprevention1,18–20. In addition to spermidine/spermine N1-acetyltransferase (SSAT), two other key enzymes of this pathway are acetylpolyamine oxidase (PAOX) and spermine oxidase (SMOX), which are H2O2 producers. PAOX and SMOX, FAD-containing amine oxidases, have been biochemically characterised in a wide variety of organisms, including vertebrates, invertebrates and yeast8,21–23. PAOX is a constitutively expressed enzyme and its preferred substrates are N1-acetylspermine (N1AcSPM) and N1-acetylspermidine24, whereas SMOX is an inducible enzyme specific for SPM8 and is highly expressed in some tissues, such as brain and skeletal muscle25–27. Recently, in addition to the cytoplasmic and nuclear SMOX isoforms, SMOX activity was detected also in mitochondria28. SMOX expression is increased in some type of cancers, it is induced by some bacterial infections and inflammatory cytokines, and by some PA analogues, such as N1,N11-bis(ethyl)norspermine (BenSPM)1,8,20,29–31. In each case, the induction of SMOX is linked to an increase of H2O2 production and DNA damage, which correlates with the risk of developing dysplasia/cancer18,20. In addition, epigenetic factors have been recently involved in the link between increased SMOX expression and carcinogenesis32.",
                "pl_xpath": "/article/body/sec[1]/p[2]"
            },
            {
                "n_rp": 25,
                "xref_id": "CIT0003",
                "rp_string": "3",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[5]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1,513)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "To reduce the naturally occurring PA availability in cancer cells, some of the developed analogues targeting the biosynthetic pathway are, for instance, difluoromethyl-ornithine, which inhibits ornithine decarboxylase (ODC, the rate-limiting enzyme in the synthetic pathway)1,3,18, methylglyoxal(bis)guanylhydrazone, which targets S-adenosylmethionine decarboxylase1,3,18 and the spermine (SPM) derivative named AMXT1501, which blocks the activity of polyamine transporters, avoiding the uptake of exogenous PA18. In the last years, the PA catabolic pathway is also emerging as a promising target for chemoprevention1,18–20. In addition to spermidine/spermine N1-acetyltransferase (SSAT), two other key enzymes of this pathway are acetylpolyamine oxidase (PAOX) and spermine oxidase (SMOX), which are H2O2 producers. PAOX and SMOX, FAD-containing amine oxidases, have been biochemically characterised in a wide variety of organisms, including vertebrates, invertebrates and yeast8,21–23. PAOX is a constitutively expressed enzyme and its preferred substrates are N1-acetylspermine (N1AcSPM) and N1-acetylspermidine24, whereas SMOX is an inducible enzyme specific for SPM8 and is highly expressed in some tissues, such as brain and skeletal muscle25–27. Recently, in addition to the cytoplasmic and nuclear SMOX isoforms, SMOX activity was detected also in mitochondria28. SMOX expression is increased in some type of cancers, it is induced by some bacterial infections and inflammatory cytokines, and by some PA analogues, such as N1,N11-bis(ethyl)norspermine (BenSPM)1,8,20,29–31. In each case, the induction of SMOX is linked to an increase of H2O2 production and DNA damage, which correlates with the risk of developing dysplasia/cancer18,20. In addition, epigenetic factors have been recently involved in the link between increased SMOX expression and carcinogenesis32.",
                "pl_xpath": "/article/body/sec[1]/p[2]"
            },
            {
                "n_rp": 26,
                "xref_id": "CIT0018",
                "rp_string": "18",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[6]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1,513)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "To reduce the naturally occurring PA availability in cancer cells, some of the developed analogues targeting the biosynthetic pathway are, for instance, difluoromethyl-ornithine, which inhibits ornithine decarboxylase (ODC, the rate-limiting enzyme in the synthetic pathway)1,3,18, methylglyoxal(bis)guanylhydrazone, which targets S-adenosylmethionine decarboxylase1,3,18 and the spermine (SPM) derivative named AMXT1501, which blocks the activity of polyamine transporters, avoiding the uptake of exogenous PA18. In the last years, the PA catabolic pathway is also emerging as a promising target for chemoprevention1,18–20. In addition to spermidine/spermine N1-acetyltransferase (SSAT), two other key enzymes of this pathway are acetylpolyamine oxidase (PAOX) and spermine oxidase (SMOX), which are H2O2 producers. PAOX and SMOX, FAD-containing amine oxidases, have been biochemically characterised in a wide variety of organisms, including vertebrates, invertebrates and yeast8,21–23. PAOX is a constitutively expressed enzyme and its preferred substrates are N1-acetylspermine (N1AcSPM) and N1-acetylspermidine24, whereas SMOX is an inducible enzyme specific for SPM8 and is highly expressed in some tissues, such as brain and skeletal muscle25–27. Recently, in addition to the cytoplasmic and nuclear SMOX isoforms, SMOX activity was detected also in mitochondria28. SMOX expression is increased in some type of cancers, it is induced by some bacterial infections and inflammatory cytokines, and by some PA analogues, such as N1,N11-bis(ethyl)norspermine (BenSPM)1,8,20,29–31. In each case, the induction of SMOX is linked to an increase of H2O2 production and DNA damage, which correlates with the risk of developing dysplasia/cancer18,20. In addition, epigenetic factors have been recently involved in the link between increased SMOX expression and carcinogenesis32.",
                "pl_xpath": "/article/body/sec[1]/p[2]"
            },
            {
                "n_rp": 27,
                "xref_id": "CIT0018",
                "rp_string": "18",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[7]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1,513)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "To reduce the naturally occurring PA availability in cancer cells, some of the developed analogues targeting the biosynthetic pathway are, for instance, difluoromethyl-ornithine, which inhibits ornithine decarboxylase (ODC, the rate-limiting enzyme in the synthetic pathway)1,3,18, methylglyoxal(bis)guanylhydrazone, which targets S-adenosylmethionine decarboxylase1,3,18 and the spermine (SPM) derivative named AMXT1501, which blocks the activity of polyamine transporters, avoiding the uptake of exogenous PA18. In the last years, the PA catabolic pathway is also emerging as a promising target for chemoprevention1,18–20. In addition to spermidine/spermine N1-acetyltransferase (SSAT), two other key enzymes of this pathway are acetylpolyamine oxidase (PAOX) and spermine oxidase (SMOX), which are H2O2 producers. PAOX and SMOX, FAD-containing amine oxidases, have been biochemically characterised in a wide variety of organisms, including vertebrates, invertebrates and yeast8,21–23. PAOX is a constitutively expressed enzyme and its preferred substrates are N1-acetylspermine (N1AcSPM) and N1-acetylspermidine24, whereas SMOX is an inducible enzyme specific for SPM8 and is highly expressed in some tissues, such as brain and skeletal muscle25–27. Recently, in addition to the cytoplasmic and nuclear SMOX isoforms, SMOX activity was detected also in mitochondria28. SMOX expression is increased in some type of cancers, it is induced by some bacterial infections and inflammatory cytokines, and by some PA analogues, such as N1,N11-bis(ethyl)norspermine (BenSPM)1,8,20,29–31. In each case, the induction of SMOX is linked to an increase of H2O2 production and DNA damage, which correlates with the risk of developing dysplasia/cancer18,20. In addition, epigenetic factors have been recently involved in the link between increased SMOX expression and carcinogenesis32.",
                "pl_xpath": "/article/body/sec[1]/p[2]"
            }
        ],
        [
            {
                "n_rp": 28,
                "xref_id": "CIT0001",
                "rp_string": "1",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[8]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),515,110)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 32,
                "xref_id": "CIT0018",
                "rp_string": "18–20",
                "pl_string": "18–20",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[9]",
                "pl_xpath": "/article/body/sec[1]/p[2]/xref[9]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),515,110)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 30,
                "xref_id": "",
                "pl_string": "18–20",
                "pl_xpath": "/article/body/sec[1]/p[2]/xref[9]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),515,110)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 31,
                "xref_id": "",
                "pl_string": "18–20",
                "pl_xpath": "/article/body/sec[1]/p[2]/xref[9]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),515,110)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 32,
                "xref_id": "CIT0018",
                "rp_string": "18–20",
                "pl_string": "18–20",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[9]",
                "pl_xpath": "/article/body/sec[1]/p[2]/xref[9]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),515,110)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 33,
                "xref_id": "CIT0008",
                "rp_string": "8",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[10]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),818,170)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 37,
                "xref_id": "CIT0021",
                "rp_string": "21–23",
                "pl_string": "21–23",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[11]",
                "pl_xpath": "/article/body/sec[1]/p[2]/xref[11]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),818,170)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 35,
                "xref_id": "",
                "pl_string": "21–23",
                "pl_xpath": "/article/body/sec[1]/p[2]/xref[11]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),818,170)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 36,
                "xref_id": "",
                "pl_string": "21–23",
                "pl_xpath": "/article/body/sec[1]/p[2]/xref[11]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),818,170)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 37,
                "xref_id": "CIT0021",
                "rp_string": "21–23",
                "pl_string": "21–23",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[11]",
                "pl_xpath": "/article/body/sec[1]/p[2]/xref[11]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),818,170)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 38,
                "xref_id": "CIT0024",
                "rp_string": "24",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[12]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),989,264)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "To reduce the naturally occurring PA availability in cancer cells, some of the developed analogues targeting the biosynthetic pathway are, for instance, difluoromethyl-ornithine, which inhibits ornithine decarboxylase (ODC, the rate-limiting enzyme in the synthetic pathway)1,3,18, methylglyoxal(bis)guanylhydrazone, which targets S-adenosylmethionine decarboxylase1,3,18 and the spermine (SPM) derivative named AMXT1501, which blocks the activity of polyamine transporters, avoiding the uptake of exogenous PA18. In the last years, the PA catabolic pathway is also emerging as a promising target for chemoprevention1,18–20. In addition to spermidine/spermine N1-acetyltransferase (SSAT), two other key enzymes of this pathway are acetylpolyamine oxidase (PAOX) and spermine oxidase (SMOX), which are H2O2 producers. PAOX and SMOX, FAD-containing amine oxidases, have been biochemically characterised in a wide variety of organisms, including vertebrates, invertebrates and yeast8,21–23. PAOX is a constitutively expressed enzyme and its preferred substrates are N1-acetylspermine (N1AcSPM) and N1-acetylspermidine24, whereas SMOX is an inducible enzyme specific for SPM8 and is highly expressed in some tissues, such as brain and skeletal muscle25–27. Recently, in addition to the cytoplasmic and nuclear SMOX isoforms, SMOX activity was detected also in mitochondria28. SMOX expression is increased in some type of cancers, it is induced by some bacterial infections and inflammatory cytokines, and by some PA analogues, such as N1,N11-bis(ethyl)norspermine (BenSPM)1,8,20,29–31. In each case, the induction of SMOX is linked to an increase of H2O2 production and DNA damage, which correlates with the risk of developing dysplasia/cancer18,20. In addition, epigenetic factors have been recently involved in the link between increased SMOX expression and carcinogenesis32.",
                "pl_xpath": "/article/body/sec[1]/p[2]"
            },
            {
                "n_rp": 39,
                "xref_id": "CIT0008",
                "rp_string": "8",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[13]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),989,264)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "To reduce the naturally occurring PA availability in cancer cells, some of the developed analogues targeting the biosynthetic pathway are, for instance, difluoromethyl-ornithine, which inhibits ornithine decarboxylase (ODC, the rate-limiting enzyme in the synthetic pathway)1,3,18, methylglyoxal(bis)guanylhydrazone, which targets S-adenosylmethionine decarboxylase1,3,18 and the spermine (SPM) derivative named AMXT1501, which blocks the activity of polyamine transporters, avoiding the uptake of exogenous PA18. In the last years, the PA catabolic pathway is also emerging as a promising target for chemoprevention1,18–20. In addition to spermidine/spermine N1-acetyltransferase (SSAT), two other key enzymes of this pathway are acetylpolyamine oxidase (PAOX) and spermine oxidase (SMOX), which are H2O2 producers. PAOX and SMOX, FAD-containing amine oxidases, have been biochemically characterised in a wide variety of organisms, including vertebrates, invertebrates and yeast8,21–23. PAOX is a constitutively expressed enzyme and its preferred substrates are N1-acetylspermine (N1AcSPM) and N1-acetylspermidine24, whereas SMOX is an inducible enzyme specific for SPM8 and is highly expressed in some tissues, such as brain and skeletal muscle25–27. Recently, in addition to the cytoplasmic and nuclear SMOX isoforms, SMOX activity was detected also in mitochondria28. SMOX expression is increased in some type of cancers, it is induced by some bacterial infections and inflammatory cytokines, and by some PA analogues, such as N1,N11-bis(ethyl)norspermine (BenSPM)1,8,20,29–31. In each case, the induction of SMOX is linked to an increase of H2O2 production and DNA damage, which correlates with the risk of developing dysplasia/cancer18,20. In addition, epigenetic factors have been recently involved in the link between increased SMOX expression and carcinogenesis32.",
                "pl_xpath": "/article/body/sec[1]/p[2]"
            },
            {
                "n_rp": 41,
                "xref_id": "CIT0025",
                "rp_string": "25–27",
                "pl_string": "To reduce the naturally occurring PA availability in cancer cells, some of the developed analogues targeting the biosynthetic pathway are, for instance, difluoromethyl-ornithine, which inhibits ornithine decarboxylase (ODC, the rate-limiting enzyme in the synthetic pathway)1,3,18, methylglyoxal(bis)guanylhydrazone, which targets S-adenosylmethionine decarboxylase1,3,18 and the spermine (SPM) derivative named AMXT1501, which blocks the activity of polyamine transporters, avoiding the uptake of exogenous PA18. In the last years, the PA catabolic pathway is also emerging as a promising target for chemoprevention1,18–20. In addition to spermidine/spermine N1-acetyltransferase (SSAT), two other key enzymes of this pathway are acetylpolyamine oxidase (PAOX) and spermine oxidase (SMOX), which are H2O2 producers. PAOX and SMOX, FAD-containing amine oxidases, have been biochemically characterised in a wide variety of organisms, including vertebrates, invertebrates and yeast8,21–23. PAOX is a constitutively expressed enzyme and its preferred substrates are N1-acetylspermine (N1AcSPM) and N1-acetylspermidine24, whereas SMOX is an inducible enzyme specific for SPM8 and is highly expressed in some tissues, such as brain and skeletal muscle25–27. Recently, in addition to the cytoplasmic and nuclear SMOX isoforms, SMOX activity was detected also in mitochondria28. SMOX expression is increased in some type of cancers, it is induced by some bacterial infections and inflammatory cytokines, and by some PA analogues, such as N1,N11-bis(ethyl)norspermine (BenSPM)1,8,20,29–31. In each case, the induction of SMOX is linked to an increase of H2O2 production and DNA damage, which correlates with the risk of developing dysplasia/cancer18,20. In addition, epigenetic factors have been recently involved in the link between increased SMOX expression and carcinogenesis32.",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[14]",
                "pl_xpath": "/article/body/sec[1]/p[2]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),989,264)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 41,
                "xref_id": "CIT0025",
                "rp_string": "25–27",
                "pl_string": "To reduce the naturally occurring PA availability in cancer cells, some of the developed analogues targeting the biosynthetic pathway are, for instance, difluoromethyl-ornithine, which inhibits ornithine decarboxylase (ODC, the rate-limiting enzyme in the synthetic pathway)1,3,18, methylglyoxal(bis)guanylhydrazone, which targets S-adenosylmethionine decarboxylase1,3,18 and the spermine (SPM) derivative named AMXT1501, which blocks the activity of polyamine transporters, avoiding the uptake of exogenous PA18. In the last years, the PA catabolic pathway is also emerging as a promising target for chemoprevention1,18–20. In addition to spermidine/spermine N1-acetyltransferase (SSAT), two other key enzymes of this pathway are acetylpolyamine oxidase (PAOX) and spermine oxidase (SMOX), which are H2O2 producers. PAOX and SMOX, FAD-containing amine oxidases, have been biochemically characterised in a wide variety of organisms, including vertebrates, invertebrates and yeast8,21–23. PAOX is a constitutively expressed enzyme and its preferred substrates are N1-acetylspermine (N1AcSPM) and N1-acetylspermidine24, whereas SMOX is an inducible enzyme specific for SPM8 and is highly expressed in some tissues, such as brain and skeletal muscle25–27. Recently, in addition to the cytoplasmic and nuclear SMOX isoforms, SMOX activity was detected also in mitochondria28. SMOX expression is increased in some type of cancers, it is induced by some bacterial infections and inflammatory cytokines, and by some PA analogues, such as N1,N11-bis(ethyl)norspermine (BenSPM)1,8,20,29–31. In each case, the induction of SMOX is linked to an increase of H2O2 production and DNA damage, which correlates with the risk of developing dysplasia/cancer18,20. In addition, epigenetic factors have been recently involved in the link between increased SMOX expression and carcinogenesis32.",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[14]",
                "pl_xpath": "/article/body/sec[1]/p[2]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),989,264)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 42,
                "xref_id": "",
                "pl_string": "25–27",
                "pl_xpath": "/article/body/sec[1]/p[2]/xref[14]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),989,264)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 43,
                "xref_id": "",
                "pl_string": "25–27",
                "pl_xpath": "/article/body/sec[1]/p[2]/xref[14]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),989,264)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 44,
                "xref_id": "CIT0028",
                "rp_string": "28",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[15]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1254,118)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 45,
                "xref_id": "CIT0001",
                "rp_string": "1",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[16]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1373,209)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 46,
                "xref_id": "CIT0008",
                "rp_string": "8",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[17]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1373,209)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 47,
                "xref_id": "CIT0020",
                "rp_string": "20",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[18]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1373,209)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 51,
                "xref_id": "CIT0029",
                "rp_string": "29–31",
                "pl_string": "29–31",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[19]",
                "pl_xpath": "/article/body/sec[1]/p[2]/xref[19]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1373,209)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 49,
                "xref_id": "",
                "pl_string": "29–31",
                "pl_xpath": "/article/body/sec[1]/p[2]/xref[19]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1373,209)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 50,
                "xref_id": "",
                "pl_string": "29–31",
                "pl_xpath": "/article/body/sec[1]/p[2]/xref[19]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1373,209)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 51,
                "xref_id": "CIT0029",
                "rp_string": "29–31",
                "pl_string": "29–31",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[19]",
                "pl_xpath": "/article/body/sec[1]/p[2]/xref[19]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1373,209)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 52,
                "xref_id": "CIT0018",
                "rp_string": "18",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[20]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1583,163)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 53,
                "xref_id": "CIT0020",
                "rp_string": "20",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[21]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1583,163)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 54,
                "xref_id": "CIT0032",
                "rp_string": "32",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[22]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1747,127)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 55,
                "xref_id": "CIT0033",
                "rp_string": "33",
                "rp_xpath": "/article/body/sec[1]/p[4]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[4]),226,317)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "Unfortunately, most of the mammalian PAOX and SMOX inhibitors currently available, suffer from poor selectivity, and overcoming this problem still remains an important goal for the development of novel pharmacological tools. SMOX and PAOX inhibitors are generally PA analogues33, such as the irreversible and “well-known” MDL 72527 (N1,N4-bis(2,3-butadienyl)-1,4-butanediamine)34 (Ki=20 and 63 μM, for purified murine PAOX and SMOX respectively)33 and other butadienyl-spermidine derivatives with improved potency with respect to MDL 7252735. Interestingly, some guanidine-containing derivatives have also shown promising inhibitory activity towards PAOX and SMOX. They include N-prenylagmatine (G3)33, which has emerged as a good and selective competitive murine PAOX inhibitor (Ki=0.8 μM for PAOX and Ki=46 μM for SMOX), and iminoctadine (also known as guazatine), as a good but non-selective murine SMOX and PAOX inhibitor (Ki ≈ 0.5 μM). Recently, the antiseptic agent chlorhexidine has also been reported to act as a competitive inhibitor of murine PAOX and SMOX36.",
                "pl_xpath": "/article/body/sec[1]/p[4]"
            },
            {
                "n_rp": 56,
                "xref_id": "CIT0034",
                "rp_string": "34",
                "rp_xpath": "/article/body/sec[1]/p[4]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[4]),226,317)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "Unfortunately, most of the mammalian PAOX and SMOX inhibitors currently available, suffer from poor selectivity, and overcoming this problem still remains an important goal for the development of novel pharmacological tools. SMOX and PAOX inhibitors are generally PA analogues33, such as the irreversible and “well-known” MDL 72527 (N1,N4-bis(2,3-butadienyl)-1,4-butanediamine)34 (Ki=20 and 63 μM, for purified murine PAOX and SMOX respectively)33 and other butadienyl-spermidine derivatives with improved potency with respect to MDL 7252735. Interestingly, some guanidine-containing derivatives have also shown promising inhibitory activity towards PAOX and SMOX. They include N-prenylagmatine (G3)33, which has emerged as a good and selective competitive murine PAOX inhibitor (Ki=0.8 μM for PAOX and Ki=46 μM for SMOX), and iminoctadine (also known as guazatine), as a good but non-selective murine SMOX and PAOX inhibitor (Ki ≈ 0.5 μM). Recently, the antiseptic agent chlorhexidine has also been reported to act as a competitive inhibitor of murine PAOX and SMOX36.",
                "pl_xpath": "/article/body/sec[1]/p[4]"
            },
            {
                "n_rp": 57,
                "xref_id": "CIT0033",
                "rp_string": "33",
                "rp_xpath": "/article/body/sec[1]/p[4]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[4]),226,317)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "Unfortunately, most of the mammalian PAOX and SMOX inhibitors currently available, suffer from poor selectivity, and overcoming this problem still remains an important goal for the development of novel pharmacological tools. SMOX and PAOX inhibitors are generally PA analogues33, such as the irreversible and “well-known” MDL 72527 (N1,N4-bis(2,3-butadienyl)-1,4-butanediamine)34 (Ki=20 and 63 μM, for purified murine PAOX and SMOX respectively)33 and other butadienyl-spermidine derivatives with improved potency with respect to MDL 7252735. Interestingly, some guanidine-containing derivatives have also shown promising inhibitory activity towards PAOX and SMOX. They include N-prenylagmatine (G3)33, which has emerged as a good and selective competitive murine PAOX inhibitor (Ki=0.8 μM for PAOX and Ki=46 μM for SMOX), and iminoctadine (also known as guazatine), as a good but non-selective murine SMOX and PAOX inhibitor (Ki ≈ 0.5 μM). Recently, the antiseptic agent chlorhexidine has also been reported to act as a competitive inhibitor of murine PAOX and SMOX36.",
                "pl_xpath": "/article/body/sec[1]/p[4]"
            },
            {
                "n_rp": 58,
                "xref_id": "CIT0035",
                "rp_string": "35",
                "rp_xpath": "/article/body/sec[1]/p[4]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[4]),226,317)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "Unfortunately, most of the mammalian PAOX and SMOX inhibitors currently available, suffer from poor selectivity, and overcoming this problem still remains an important goal for the development of novel pharmacological tools. SMOX and PAOX inhibitors are generally PA analogues33, such as the irreversible and “well-known” MDL 72527 (N1,N4-bis(2,3-butadienyl)-1,4-butanediamine)34 (Ki=20 and 63 μM, for purified murine PAOX and SMOX respectively)33 and other butadienyl-spermidine derivatives with improved potency with respect to MDL 7252735. Interestingly, some guanidine-containing derivatives have also shown promising inhibitory activity towards PAOX and SMOX. They include N-prenylagmatine (G3)33, which has emerged as a good and selective competitive murine PAOX inhibitor (Ki=0.8 μM for PAOX and Ki=46 μM for SMOX), and iminoctadine (also known as guazatine), as a good but non-selective murine SMOX and PAOX inhibitor (Ki ≈ 0.5 μM). Recently, the antiseptic agent chlorhexidine has also been reported to act as a competitive inhibitor of murine PAOX and SMOX36.",
                "pl_xpath": "/article/body/sec[1]/p[4]"
            }
        ],
        [
            {
                "n_rp": 59,
                "xref_id": "CIT0033",
                "rp_string": "33",
                "rp_xpath": "/article/body/sec[1]/p[4]/xref[5]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[4]),666,275)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 60,
                "xref_id": "CIT0036",
                "rp_string": "36",
                "rp_xpath": "/article/body/sec[1]/p[4]/xref[6]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[4]),942,128)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 61,
                "xref_id": "CIT0037",
                "rp_string": "37",
                "rp_xpath": "/article/body/sec[1]/p[5]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[5]),141,182)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 62,
                "xref_id": "CIT0039",
                "rp_string": "39",
                "rp_xpath": "/article/body/sec[1]/p[5]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[5]),141,182)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 63,
                "xref_id": "CIT0040",
                "rp_string": "40",
                "rp_xpath": "/article/body/sec[1]/p[5]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[5]),563,141)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 64,
                "xref_id": "CIT0037",
                "rp_string": "37",
                "rp_xpath": "/article/body/sec[1]/p[5]/xref[5]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[5]),705,290)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 65,
                "xref_id": "CIT0037",
                "rp_string": "37",
                "rp_xpath": "/article/body/sec[1]/p[6]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[6]),1,259)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 66,
                "xref_id": "CIT0041",
                "rp_string": "41",
                "rp_xpath": "/article/body/sec[1]/p[6]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[6]),1,259)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 67,
                "xref_id": "CIT0042",
                "rp_string": "42",
                "rp_xpath": "/article/body/sec[1]/p[6]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[6]),1,259)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 68,
                "xref_id": "CIT0043",
                "rp_string": "43",
                "rp_xpath": "/article/body/sec[1]/p[8]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[8]),1,299)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_xpath": "substring(string(/article/body/sec[1]/p[8]),60,5)",
                "pl_string": "s43,4"
            },
            {
                "n_rp": 69,
                "xref_id": "CIT0044",
                "rp_string": "44",
                "rp_xpath": "/article/body/sec[1]/p[8]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[8]),1,299)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_xpath": "substring(string(/article/body/sec[1]/p[8]),60,5)",
                "pl_string": "s43,4"
            }
        ],
        [
            {
                "n_rp": 70,
                "xref_id": "CIT0045",
                "rp_string": "45",
                "rp_xpath": "/article/body/sec[2]/sec[1]/p[2]/xref",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[1]/p[2]),1,143)",
                "containers_title": [
                    "Materials and methods",
                    "Materials and instrumentations"
                ]
            }
        ],
        [
            {
                "n_rp": 71,
                "xref_id": "CIT0046",
                "rp_string": "46",
                "rp_xpath": "/article/body/sec[2]/sec[1]/p[3]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[1]/p[3]),1,286)",
                "containers_title": [
                    "Materials and methods",
                    "Materials and instrumentations"
                ],
                "pl_string": "PA analogues were synthesised as previously reported (compounds 1, 8 and 9 in Bonaiuto et al.46; compounds 2–7 in Bonaiuto et al.,47; methoctramine derivatives 10–12 in Melchiorre et al.,48, and Minarini et al.,49; compound 13 in Tumiatti et al.,50; compound 14 in Melchiorre et al.,51.",
                "pl_xpath": "/article/body/sec[2]/sec[1]/p[3]"
            },
            {
                "n_rp": 72,
                "xref_id": "CIT0047",
                "rp_string": "47",
                "rp_xpath": "/article/body/sec[2]/sec[1]/p[3]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[1]/p[3]),1,286)",
                "containers_title": [
                    "Materials and methods",
                    "Materials and instrumentations"
                ],
                "pl_string": "PA analogues were synthesised as previously reported (compounds 1, 8 and 9 in Bonaiuto et al.46; compounds 2–7 in Bonaiuto et al.,47; methoctramine derivatives 10–12 in Melchiorre et al.,48, and Minarini et al.,49; compound 13 in Tumiatti et al.,50; compound 14 in Melchiorre et al.,51.",
                "pl_xpath": "/article/body/sec[2]/sec[1]/p[3]"
            },
            {
                "n_rp": 73,
                "xref_id": "CIT0048",
                "rp_string": "48",
                "rp_xpath": "/article/body/sec[2]/sec[1]/p[3]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[1]/p[3]),1,286)",
                "containers_title": [
                    "Materials and methods",
                    "Materials and instrumentations"
                ],
                "pl_string": "PA analogues were synthesised as previously reported (compounds 1, 8 and 9 in Bonaiuto et al.46; compounds 2–7 in Bonaiuto et al.,47; methoctramine derivatives 10–12 in Melchiorre et al.,48, and Minarini et al.,49; compound 13 in Tumiatti et al.,50; compound 14 in Melchiorre et al.,51.",
                "pl_xpath": "/article/body/sec[2]/sec[1]/p[3]"
            },
            {
                "n_rp": 74,
                "xref_id": "CIT0049",
                "rp_string": "49",
                "rp_xpath": "/article/body/sec[2]/sec[1]/p[3]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[1]/p[3]),1,286)",
                "containers_title": [
                    "Materials and methods",
                    "Materials and instrumentations"
                ],
                "pl_string": "PA analogues were synthesised as previously reported (compounds 1, 8 and 9 in Bonaiuto et al.46; compounds 2–7 in Bonaiuto et al.,47; methoctramine derivatives 10–12 in Melchiorre et al.,48, and Minarini et al.,49; compound 13 in Tumiatti et al.,50; compound 14 in Melchiorre et al.,51.",
                "pl_xpath": "/article/body/sec[2]/sec[1]/p[3]"
            },
            {
                "n_rp": 75,
                "xref_id": "CIT0050",
                "rp_string": "50",
                "rp_xpath": "/article/body/sec[2]/sec[1]/p[3]/xref[5]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[1]/p[3]),1,286)",
                "containers_title": [
                    "Materials and methods",
                    "Materials and instrumentations"
                ],
                "pl_string": "PA analogues were synthesised as previously reported (compounds 1, 8 and 9 in Bonaiuto et al.46; compounds 2–7 in Bonaiuto et al.,47; methoctramine derivatives 10–12 in Melchiorre et al.,48, and Minarini et al.,49; compound 13 in Tumiatti et al.,50; compound 14 in Melchiorre et al.,51.",
                "pl_xpath": "/article/body/sec[2]/sec[1]/p[3]"
            },
            {
                "n_rp": 76,
                "xref_id": "CIT0051",
                "rp_string": "51",
                "rp_xpath": "/article/body/sec[2]/sec[1]/p[3]/xref[6]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[1]/p[3]),1,286)",
                "containers_title": [
                    "Materials and methods",
                    "Materials and instrumentations"
                ],
                "pl_string": "PA analogues were synthesised as previously reported (compounds 1, 8 and 9 in Bonaiuto et al.46; compounds 2–7 in Bonaiuto et al.,47; methoctramine derivatives 10–12 in Melchiorre et al.,48, and Minarini et al.,49; compound 13 in Tumiatti et al.,50; compound 14 in Melchiorre et al.,51.",
                "pl_xpath": "/article/body/sec[2]/sec[1]/p[3]"
            }
        ],
        [
            {
                "n_rp": 77,
                "xref_id": "CIT0033",
                "rp_string": "33",
                "rp_xpath": "/article/body/sec[2]/sec[2]/p/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[2]/p),1,159)",
                "containers_title": [
                    "Materials and methods",
                    "Expression and purification of PAOX and SMOX proteins in E. coli cells"
                ],
                "pl_string": "The recombinant PAOX and SMOX proteins were expressed in E. coli BL21 DE3 cells and purified according to Bianchi et al.33 and Cervelli et al.25, respectively. Purified recombinant proteins were analysed by SDS/PAGE electrophoresis to assess the grade of purity. Protein concentration was measured by the 460-nm molar extinction coefficient (ε460=9000 M−1 cm−1) which accounts for FAD absorption.",
                "pl_xpath": "/article/body/sec[2]/sec[2]/p"
            },
            {
                "n_rp": 78,
                "xref_id": "CIT0025",
                "rp_string": "25",
                "rp_xpath": "/article/body/sec[2]/sec[2]/p/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[2]/p),1,159)",
                "containers_title": [
                    "Materials and methods",
                    "Expression and purification of PAOX and SMOX proteins in E. coli cells"
                ],
                "pl_string": "The recombinant PAOX and SMOX proteins were expressed in E. coli BL21 DE3 cells and purified according to Bianchi et al.33 and Cervelli et al.25, respectively. Purified recombinant proteins were analysed by SDS/PAGE electrophoresis to assess the grade of purity. Protein concentration was measured by the 460-nm molar extinction coefficient (ε460=9000 M−1 cm−1) which accounts for FAD absorption.",
                "pl_xpath": "/article/body/sec[2]/sec[2]/p"
            }
        ],
        [
            {
                "n_rp": 79,
                "xref_id": "CIT0052",
                "rp_string": "52",
                "rp_xpath": "/article/body/sec[2]/sec[3]/p[1]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[3]/p[1]),121,82)",
                "containers_title": [
                    "Materials and methods",
                    "Amine oxidase activity assay"
                ]
            }
        ],
        [
            {
                "n_rp": 80,
                "xref_id": "CIT0053",
                "rp_string": "53",
                "rp_xpath": "/article/body/sec[2]/sec[3]/p[1]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[3]/p[1]),274,112)",
                "containers_title": [
                    "Materials and methods",
                    "Amine oxidase activity assay"
                ]
            }
        ],
        [
            {
                "n_rp": 81,
                "xref_id": "CIT0037",
                "rp_string": "37",
                "rp_xpath": "/article/body/sec[2]/sec[4]/p[1]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[4]/p[1]),1,103)",
                "containers_title": [
                    "Materials and methods",
                    "Docking simulations"
                ]
            }
        ],
        [
            {
                "n_rp": 82,
                "xref_id": "CIT0042",
                "rp_string": "42",
                "rp_xpath": "/article/body/sec[2]/sec[4]/p[1]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[4]/p[1]),243,204)",
                "containers_title": [
                    "Materials and methods",
                    "Docking simulations"
                ],
                "pl_string": "Docking simulations were performed with the recently solved crystal structure of PAOX (PDB ID: 5LFO37). The three-dimensional structure of small molecule ligands was built with Schrödinger Maestro 10.1 (Schrödinger, LLC, New York, NY, 2015). As literature data indicate that PAs bind within the PAOX active site in tri-protonated form42, the atomic charges of the ligands in this form were calculated with the AtomicChargeCalculator web server54. Simulations were carried out with AutoDock Vina55. In all simulations, to carry out “blind” predictions of small-molecule binding sites, the search space (docking grid) included the whole PAOX structure. The grid spacing was set to 1 Å per grid unit, and the exhaustiveness parameter was increased from the default value of 8–24, as suggested by Autodock Vina developers for grid sizes larger than 27,000 Å3 (see http://vina.scripps.edu/tutorial.html).",
                "pl_xpath": "/article/body/sec[2]/sec[4]/p[1]"
            },
            {
                "n_rp": 83,
                "xref_id": "CIT0054",
                "rp_string": "54",
                "rp_xpath": "/article/body/sec[2]/sec[4]/p[1]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[4]/p[1]),243,204)",
                "containers_title": [
                    "Materials and methods",
                    "Docking simulations"
                ],
                "pl_string": "Docking simulations were performed with the recently solved crystal structure of PAOX (PDB ID: 5LFO37). The three-dimensional structure of small molecule ligands was built with Schrödinger Maestro 10.1 (Schrödinger, LLC, New York, NY, 2015). As literature data indicate that PAs bind within the PAOX active site in tri-protonated form42, the atomic charges of the ligands in this form were calculated with the AtomicChargeCalculator web server54. Simulations were carried out with AutoDock Vina55. In all simulations, to carry out “blind” predictions of small-molecule binding sites, the search space (docking grid) included the whole PAOX structure. The grid spacing was set to 1 Å per grid unit, and the exhaustiveness parameter was increased from the default value of 8–24, as suggested by Autodock Vina developers for grid sizes larger than 27,000 Å3 (see http://vina.scripps.edu/tutorial.html).",
                "pl_xpath": "/article/body/sec[2]/sec[4]/p[1]"
            }
        ],
        [
            {
                "n_rp": 84,
                "xref_id": "CIT0055",
                "rp_string": "55",
                "rp_xpath": "/article/body/sec[2]/sec[4]/p[1]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[4]/p[1]),448,50)",
                "containers_title": [
                    "Materials and methods",
                    "Docking simulations"
                ]
            }
        ],
        [
            {
                "n_rp": 85,
                "xref_id": "CIT0003",
                "rp_string": "3",
                "rp_xpath": "/article/body/sec[2]/sec[4]/p[1]/xref[5]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[4]/p[1]),652,248)",
                "containers_title": [
                    "Materials and methods",
                    "Docking simulations"
                ]
            }
        ],
        [
            {
                "n_rp": 86,
                "xref_id": "CIT0056",
                "rp_string": "56",
                "rp_xpath": "/article/body/sec[2]/sec[6]/p/xref",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[6]/p),1,184)",
                "containers_title": [
                    "Materials and methods",
                    "Western blot analysis"
                ]
            }
        ],
        [
            {
                "n_rp": 87,
                "xref_id": "CIT0033",
                "rp_string": "33",
                "rp_xpath": "/article/body/sec[3]/sec[1]/p/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[1]/p),841,131)",
                "containers_title": [
                    "Results",
                    "Selection of polyamine analogues"
                ]
            }
        ],
        [
            {
                "n_rp": 88,
                "xref_id": "CIT0046",
                "rp_string": "46",
                "rp_xpath": "/article/body/sec[3]/sec[1]/table-wrap/table-wrap-foot/fn[1]/p/xref",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[1]/table-wrap/table-wrap-foot/fn[1]/p),1,41)",
                "containers_title": [
                    "Results",
                    "Selection of polyamine analogues"
                ]
            }
        ],
        [
            {
                "n_rp": 89,
                "xref_id": "CIT0047",
                "rp_string": "47",
                "rp_xpath": "/article/body/sec[3]/sec[1]/table-wrap/table-wrap-foot/fn[2]/p/xref",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[1]/table-wrap/table-wrap-foot/fn[2]/p),1,41)",
                "containers_title": [
                    "Results",
                    "Selection of polyamine analogues"
                ]
            }
        ],
        [
            {
                "n_rp": 90,
                "xref_id": "CIT0048",
                "rp_string": "48",
                "rp_xpath": "/article/body/sec[3]/sec[1]/table-wrap/table-wrap-foot/fn[3]/p/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[1]/table-wrap/table-wrap-foot/fn[3]/p),1,202)",
                "containers_title": [
                    "Results",
                    "Selection of polyamine analogues"
                ],
                "pl_string": "cMethoctramine derivatives were synthesised as previously reported: methoctramine (10) in Melchiorre et al.48 and Minarini et al.49; 13 in Tumiatti et al.50 and Caproctamine (14) in Melchiorre et al.51.",
                "pl_xpath": "/article/body/sec[3]/sec[1]/table-wrap/table-wrap-foot/fn[3]/p"
            },
            {
                "n_rp": 91,
                "xref_id": "CIT0049",
                "rp_string": "49",
                "rp_xpath": "/article/body/sec[3]/sec[1]/table-wrap/table-wrap-foot/fn[3]/p/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[1]/table-wrap/table-wrap-foot/fn[3]/p),1,202)",
                "containers_title": [
                    "Results",
                    "Selection of polyamine analogues"
                ],
                "pl_string": "cMethoctramine derivatives were synthesised as previously reported: methoctramine (10) in Melchiorre et al.48 and Minarini et al.49; 13 in Tumiatti et al.50 and Caproctamine (14) in Melchiorre et al.51.",
                "pl_xpath": "/article/body/sec[3]/sec[1]/table-wrap/table-wrap-foot/fn[3]/p"
            },
            {
                "n_rp": 92,
                "xref_id": "CIT0050",
                "rp_string": "50",
                "rp_xpath": "/article/body/sec[3]/sec[1]/table-wrap/table-wrap-foot/fn[3]/p/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[1]/table-wrap/table-wrap-foot/fn[3]/p),1,202)",
                "containers_title": [
                    "Results",
                    "Selection of polyamine analogues"
                ],
                "pl_string": "cMethoctramine derivatives were synthesised as previously reported: methoctramine (10) in Melchiorre et al.48 and Minarini et al.49; 13 in Tumiatti et al.50 and Caproctamine (14) in Melchiorre et al.51.",
                "pl_xpath": "/article/body/sec[3]/sec[1]/table-wrap/table-wrap-foot/fn[3]/p"
            },
            {
                "n_rp": 93,
                "xref_id": "CIT0051",
                "rp_string": "51",
                "rp_xpath": "/article/body/sec[3]/sec[1]/table-wrap/table-wrap-foot/fn[3]/p/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[1]/table-wrap/table-wrap-foot/fn[3]/p),1,202)",
                "containers_title": [
                    "Results",
                    "Selection of polyamine analogues"
                ],
                "pl_string": "cMethoctramine derivatives were synthesised as previously reported: methoctramine (10) in Melchiorre et al.48 and Minarini et al.49; 13 in Tumiatti et al.50 and Caproctamine (14) in Melchiorre et al.51.",
                "pl_xpath": "/article/body/sec[3]/sec[1]/table-wrap/table-wrap-foot/fn[3]/p"
            }
        ],
        [
            {
                "n_rp": 94,
                "xref_id": "CIT0057",
                "rp_string": "57",
                "rp_xpath": "/article/body/sec[3]/sec[2]/p[1]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[2]/p[1]),198,112)",
                "containers_title": [
                    "Results",
                    "Polyamine analogues as potential substrates of SMOX and PAOX"
                ]
            }
        ],
        [
            {
                "n_rp": 95,
                "xref_id": "CIT0057",
                "rp_string": "57",
                "rp_xpath": "/article/body/sec[3]/sec[2]/table-wrap/table-wrap-foot/fn[3]/p/xref",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[2]/table-wrap/table-wrap-foot/fn[3]/p),1,48)",
                "containers_title": [
                    "Results",
                    "Polyamine analogues as potential substrates of SMOX and PAOX"
                ]
            }
        ],
        [
            {
                "n_rp": 96,
                "xref_id": "CIT0033",
                "rp_string": "33",
                "rp_xpath": "/article/body/sec[3]/sec[3]/p/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[3]/p),1,219)",
                "containers_title": [
                    "Results",
                    "Screening and selection of potential inhibitors"
                ]
            }
        ],
        [
            {
                "n_rp": 97,
                "xref_id": "CIT0036",
                "rp_string": "36",
                "rp_xpath": "/article/body/sec[3]/sec[3]/p/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[3]/p),1,219)",
                "containers_title": [
                    "Results",
                    "Screening and selection of potential inhibitors"
                ]
            }
        ],
        [
            {
                "n_rp": 98,
                "xref_id": "CIT0033",
                "rp_string": "33",
                "rp_xpath": "/article/body/sec[3]/sec[4]/table-wrap/table-wrap-foot/fn[2]/p/xref",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[4]/table-wrap/table-wrap-foot/fn[2]/p),1,23)",
                "containers_title": [
                    "Results",
                    "Kinetic characterisation of the most effective inhibitors of SMOX and PAOX activity"
                ]
            }
        ],
        [
            {
                "n_rp": 99,
                "xref_id": "CIT0039",
                "rp_string": "39",
                "rp_xpath": "/article/body/sec[3]/sec[5]/p[3]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[5]/p[3]),1,172)",
                "containers_title": [
                    "Results",
                    "Docking simulations of selected compounds on PAOX crystal structure"
                ]
            }
        ],
        [
            {
                "n_rp": 100,
                "xref_id": "CIT0046",
                "rp_string": "46",
                "rp_xpath": "/article/body/sec[3]/sec[6]/p[1]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[6]/p[1]),230,312)",
                "containers_title": [
                    "Results",
                    "Biological activity of methoctramine as inhibitor: selectivity towards other AOs and in cell activity"
                ]
            }
        ],
        [
            {
                "n_rp": 101,
                "xref_id": "CIT0033",
                "rp_string": "33",
                "rp_xpath": "/article/body/sec[3]/sec[6]/p[1]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[6]/p[1]),834,346)",
                "containers_title": [
                    "Results",
                    "Biological activity of methoctramine as inhibitor: selectivity towards other AOs and in cell activity"
                ]
            }
        ],
        [
            {
                "n_rp": 102,
                "xref_id": "CIT0058",
                "rp_string": "58",
                "rp_xpath": "/article/body/sec[3]/sec[6]/p[1]/xref[5]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[6]/p[1]),834,346)",
                "containers_title": [
                    "Results",
                    "Biological activity of methoctramine as inhibitor: selectivity towards other AOs and in cell activity"
                ]
            }
        ],
        [
            {
                "n_rp": 103,
                "xref_id": "CIT0047",
                "rp_string": "47",
                "rp_xpath": "/article/body/sec[3]/sec[6]/table-wrap/table-wrap-foot/fn[2]/p/xref",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[6]/table-wrap/table-wrap-foot/fn[2]/p),1,29)",
                "containers_title": [
                    "Results",
                    "Biological activity of methoctramine as inhibitor: selectivity towards other AOs and in cell activity"
                ]
            }
        ],
        [
            {
                "n_rp": 104,
                "xref_id": "CIT0046",
                "rp_string": "46",
                "rp_xpath": "/article/body/sec[3]/sec[6]/table-wrap/table-wrap-foot/fn[3]/p/xref",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[6]/table-wrap/table-wrap-foot/fn[3]/p),1,29)",
                "containers_title": [
                    "Results",
                    "Biological activity of methoctramine as inhibitor: selectivity towards other AOs and in cell activity"
                ]
            }
        ],
        [
            {
                "n_rp": 105,
                "xref_id": "CIT0059",
                "rp_string": "59",
                "rp_xpath": "/article/body/sec[3]/sec[6]/p[3]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[6]/p[3]),275,349)",
                "containers_title": [
                    "Results",
                    "Biological activity of methoctramine as inhibitor: selectivity towards other AOs and in cell activity"
                ]
            }
        ],
        [
            {
                "n_rp": 109,
                "xref_id": "CIT0060",
                "rp_string": "60–62",
                "pl_string": "60–62",
                "rp_xpath": "/article/body/sec[3]/sec[6]/p[3]/xref[2]",
                "pl_xpath": "/article/body/sec[3]/sec[6]/p[3]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[6]/p[3]),275,349)",
                "containers_title": [
                    "Results",
                    "Biological activity of methoctramine as inhibitor: selectivity towards other AOs and in cell activity"
                ]
            },
            {
                "n_rp": 110,
                "xref_id": "",
                "pl_string": "60–62",
                "pl_xpath": "/article/body/sec[3]/sec[6]/p[3]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[6]/p[3]),275,349)",
                "containers_title": [
                    "Results",
                    "Biological activity of methoctramine as inhibitor: selectivity towards other AOs and in cell activity"
                ]
            },
            {
                "n_rp": 111,
                "xref_id": "",
                "pl_string": "60–62",
                "pl_xpath": "/article/body/sec[3]/sec[6]/p[3]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[6]/p[3]),275,349)",
                "containers_title": [
                    "Results",
                    "Biological activity of methoctramine as inhibitor: selectivity towards other AOs and in cell activity"
                ]
            }
        ],
        [
            {
                "n_rp": 109,
                "xref_id": "CIT0060",
                "rp_string": "60–62",
                "pl_string": "60–62",
                "rp_xpath": "/article/body/sec[3]/sec[6]/p[3]/xref[2]",
                "pl_xpath": "/article/body/sec[3]/sec[6]/p[3]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[6]/p[3]),275,349)",
                "containers_title": [
                    "Results",
                    "Biological activity of methoctramine as inhibitor: selectivity towards other AOs and in cell activity"
                ]
            },
            {
                "n_rp": 110,
                "xref_id": "",
                "pl_string": "60–62",
                "pl_xpath": "/article/body/sec[3]/sec[6]/p[3]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[6]/p[3]),275,349)",
                "containers_title": [
                    "Results",
                    "Biological activity of methoctramine as inhibitor: selectivity towards other AOs and in cell activity"
                ]
            },
            {
                "n_rp": 111,
                "xref_id": "",
                "pl_string": "60–62",
                "pl_xpath": "/article/body/sec[3]/sec[6]/p[3]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[6]/p[3]),275,349)",
                "containers_title": [
                    "Results",
                    "Biological activity of methoctramine as inhibitor: selectivity towards other AOs and in cell activity"
                ]
            }
        ],
        [
            {
                "n_rp": 112,
                "xref_id": "CIT0061",
                "rp_string": "61",
                "rp_xpath": "/article/body/sec[3]/sec[6]/p[4]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[6]/p[4]),167,143)",
                "containers_title": [
                    "Results",
                    "Biological activity of methoctramine as inhibitor: selectivity towards other AOs and in cell activity"
                ]
            }
        ],
        [
            {
                "n_rp": 113,
                "xref_id": "CIT0001",
                "rp_string": "1",
                "rp_xpath": "/article/body/sec[4]/p[1]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[4]/p[1]),1,186)",
                "containers_title": [
                    "Discussion"
                ]
            }
        ],
        [
            {
                "n_rp": 114,
                "xref_id": "CIT0014",
                "rp_string": "14",
                "rp_xpath": "/article/body/sec[4]/p[1]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[4]/p[1]),1,186)",
                "containers_title": [
                    "Discussion"
                ]
            }
        ],
        [
            {
                "n_rp": 115,
                "xref_id": "CIT0016",
                "rp_string": "16",
                "rp_xpath": "/article/body/sec[4]/p[1]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[4]/p[1]),1,186)",
                "containers_title": [
                    "Discussion"
                ]
            }
        ],
        [
            {
                "n_rp": 116,
                "xref_id": "CIT0018",
                "rp_string": "18",
                "rp_xpath": "/article/body/sec[4]/p[1]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[4]/p[1]),1,186)",
                "containers_title": [
                    "Discussion"
                ]
            }
        ],
        [
            {
                "n_rp": 117,
                "xref_id": "CIT0012",
                "rp_string": "12",
                "rp_xpath": "/article/body/sec[4]/p[2]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[4]/p[2]),166,242)",
                "containers_title": [
                    "Discussion"
                ]
            }
        ],
        [
            {
                "n_rp": 118,
                "xref_id": "CIT0013",
                "rp_string": "13",
                "rp_xpath": "/article/body/sec[4]/p[2]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[4]/p[2]),166,242)",
                "containers_title": [
                    "Discussion"
                ]
            }
        ],
        [
            {
                "n_rp": 119,
                "xref_id": "CIT0063",
                "rp_string": "63",
                "rp_xpath": "/article/body/sec[4]/p[2]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[4]/p[2]),166,242)",
                "containers_title": [
                    "Discussion"
                ]
            }
        ],
        [
            {
                "n_rp": 120,
                "xref_id": "CIT0064",
                "rp_string": "64",
                "rp_xpath": "/article/body/sec[4]/p[2]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[4]/p[2]),166,242)",
                "containers_title": [
                    "Discussion"
                ]
            }
        ],
        [
            {
                "n_rp": 121,
                "xref_id": "CIT0024",
                "rp_string": "24",
                "rp_xpath": "/article/body/sec[4]/p[2]/xref[5]",
                "context_xpath": "substring(string(/article/body/sec[4]/p[2]),409,396)",
                "containers_title": [
                    "Discussion"
                ],
                "pl_string": "(H2O2 and acrolein) was induced, leading to apoptosis and inhibition of tumour growth12,13,63,64. In previous studies, among the various types of PA analogues investigated to discover selective SMOX vs PAOX substrates24,57,65–67, the pentamine N1-(3-aminopropyl)",
                "pl_xpath": "substring(string(/article/body/sec[4]/p[2]),311,262)"
            },
            {
                "n_rp": 122,
                "xref_id": "CIT0057",
                "rp_string": "57",
                "rp_xpath": "/article/body/sec[4]/p[2]/xref[6]",
                "context_xpath": "substring(string(/article/body/sec[4]/p[2]),409,396)",
                "containers_title": [
                    "Discussion"
                ],
                "pl_string": "(H2O2 and acrolein) was induced, leading to apoptosis and inhibition of tumour growth12,13,63,64. In previous studies, among the various types of PA analogues investigated to discover selective SMOX vs PAOX substrates24,57,65–67, the pentamine N1-(3-aminopropyl)",
                "pl_xpath": "substring(string(/article/body/sec[4]/p[2]),311,262)"
            },
            {
                "n_rp": 125,
                "xref_id": "CIT0065",
                "rp_string": "65–67",
                "pl_string": "(H2O2 and acrolein) was induced, leading to apoptosis and inhibition of tumour growth12,13,63,64. In previous studies, among the various types of PA analogues investigated to discover selective SMOX vs PAOX substrates24,57,65–67, the pentamine N1-(3-aminopropyl)",
                "rp_xpath": "/article/body/sec[4]/p[2]/xref[7]",
                "pl_xpath": "substring(string(/article/body/sec[4]/p[2]),311,262)",
                "context_xpath": "substring(string(/article/body/sec[4]/p[2]),409,396)",
                "containers_title": [
                    "Discussion"
                ]
            },
            {
                "n_rp": 124,
                "xref_id": "CIT0067",
                "rp_string": "67",
                "rp_xpath": "/article/body/sec[4]/p[2]/xref[8]",
                "context_xpath": "substring(string(/article/body/sec[4]/p[2]),409,396)",
                "containers_title": [
                    "Discussion"
                ],
                "pl_string": "(3343 in Takao et al.67)",
                "pl_xpath": "substring(string(/article/body/sec[4]/p[2]),647,24)"
            }
        ],
        [
            {
                "n_rp": 125,
                "xref_id": "CIT0065",
                "rp_string": "65–67",
                "pl_string": "(H2O2 and acrolein) was induced, leading to apoptosis and inhibition of tumour growth12,13,63,64. In previous studies, among the various types of PA analogues investigated to discover selective SMOX vs PAOX substrates24,57,65–67, the pentamine N1-(3-aminopropyl)",
                "rp_xpath": "/article/body/sec[4]/p[2]/xref[7]",
                "pl_xpath": "substring(string(/article/body/sec[4]/p[2]),311,262)",
                "context_xpath": "substring(string(/article/body/sec[4]/p[2]),409,396)",
                "containers_title": [
                    "Discussion"
                ]
            },
            {
                "n_rp": 126,
                "xref_id": "",
                "pl_string": "65–67",
                "pl_xpath": "/article/body/sec[4]/p[2]/xref[7]",
                "context_xpath": "substring(string(/article/body/sec[4]/p[2]),409,396)",
                "containers_title": [
                    "Discussion"
                ]
            },
            {
                "n_rp": 127,
                "xref_id": "",
                "pl_string": "65–67",
                "pl_xpath": "/article/body/sec[4]/p[2]/xref[7]",
                "context_xpath": "substring(string(/article/body/sec[4]/p[2]),409,396)",
                "containers_title": [
                    "Discussion"
                ]
            }
        ],
        [
            {
                "n_rp": 128,
                "xref_id": "CIT0012",
                "rp_string": "12",
                "rp_xpath": "/article/body/sec[4]/p[4]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[4]/p[4]),520,197)",
                "containers_title": [
                    "Discussion"
                ]
            }
        ],
        [
            {
                "n_rp": 129,
                "xref_id": "CIT0013",
                "rp_string": "13",
                "rp_xpath": "/article/body/sec[4]/p[4]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[4]/p[4]),520,197)",
                "containers_title": [
                    "Discussion"
                ]
            }
        ],
        [
            {
                "n_rp": 130,
                "xref_id": "CIT0029",
                "rp_string": "29",
                "rp_xpath": "/article/body/sec[4]/p[5]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[4]/p[5]),1,183)",
                "containers_title": [
                    "Discussion"
                ]
            }
        ],
        [
            {
                "n_rp": 131,
                "xref_id": "CIT0018",
                "rp_string": "18",
                "rp_xpath": "/article/body/sec[4]/p[5]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[4]/p[5]),443,140)",
                "containers_title": [
                    "Discussion"
                ]
            }
        ],
        [
            {
                "n_rp": 132,
                "xref_id": "CIT0020",
                "rp_string": "20",
                "rp_xpath": "/article/body/sec[4]/p[5]/xref[5]",
                "context_xpath": "substring(string(/article/body/sec[4]/p[5]),443,140)",
                "containers_title": [
                    "Discussion"
                ]
            }
        ],
        [
            {
                "n_rp": 133,
                "xref_id": "CIT0070",
                "rp_string": "70",
                "rp_xpath": "/article/body/sec[4]/p[7]/xref",
                "context_xpath": "substring(string(/article/body/sec[4]/p[7]),1,338)",
                "containers_title": [
                    "Discussion"
                ]
            }
        ],
        [
            {
                "n_rp": 134,
                "xref_id": "CIT0071",
                "rp_string": "71",
                "rp_xpath": "/article/body/sec[4]/p[8]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[4]/p[8]),1,321)",
                "containers_title": [
                    "Discussion"
                ],
                "pl_string": "Taking into account the low cytotoxicity of compound 10 (methoctramine)71,72 and that, at a concentration of 10 μM, it did not significantly affect other targets of PA metabolism (such as ODC and SSAT)71, methoctramine emerged as a very promising tool in the design of potential drugs targeting the PA catabolism pathway.",
                "pl_xpath": "/article/body/sec[4]/p[8]"
            },
            {
                "n_rp": 135,
                "xref_id": "CIT0072",
                "rp_string": "72",
                "rp_xpath": "/article/body/sec[4]/p[8]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[4]/p[8]),1,321)",
                "containers_title": [
                    "Discussion"
                ],
                "pl_string": "Taking into account the low cytotoxicity of compound 10 (methoctramine)71,72 and that, at a concentration of 10 μM, it did not significantly affect other targets of PA metabolism (such as ODC and SSAT)71, methoctramine emerged as a very promising tool in the design of potential drugs targeting the PA catabolism pathway.",
                "pl_xpath": "/article/body/sec[4]/p[8]"
            },
            {
                "n_rp": 136,
                "xref_id": "CIT0071",
                "rp_string": "71",
                "rp_xpath": "/article/body/sec[4]/p[8]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[4]/p[8]),1,321)",
                "containers_title": [
                    "Discussion"
                ],
                "pl_string": "Taking into account the low cytotoxicity of compound 10 (methoctramine)71,72 and that, at a concentration of 10 μM, it did not significantly affect other targets of PA metabolism (such as ODC and SSAT)71, methoctramine emerged as a very promising tool in the design of potential drugs targeting the PA catabolism pathway.",
                "pl_xpath": "/article/body/sec[4]/p[8]"
            }
        ]
    ]
}